Cost-Effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency Virus
Archives of Internal Medicine
doi 10.1001/archinte.164.1.46
Full Text
Abstract
Available in
Date
January 12, 2004
Authors
Publisher
American Medical Association (AMA)